Dr. Andrew Xiao is an associate professor in the Department of Genetics at the Yale University School of Medicine. He is a member of the Yale Stem Cell Center. Dr. Xiao’s laboratory focuses on epigenetic regulation in pluripotent stem cells, including embryonic stem cells and induced pluripotenct stem cells (iPSC). His laboratory has made significant contributions to the understanding of the maintenance of pluripotency, as well as the recent discovery of novel epigenetic mechanisms, i.e., N6-methyl-adenine, in mammalian genomes. Dr. Xiao received his Ph.D degree from Terry Van Dyke’s lab at UNC-Chapel Hill and postdoctoral training from David Allis’ lab at Rockefeller University. Since 2009, Andrew Xiao is a recipient of the NCI Howard Temin Award in Cancer Research (K99/R00) and in 2012, he received the New Scholar Award from the Ellison Medical Foundation. He is a recipient of the Outstanding Early Investigator Awards from the Ludwig Family Foundation since 2015.
|Outstanding Early Investigator Awards||Ludwig Family Foundation||2018|
|Blavatnik Innovation Award||2017|
|New Scholar Award||Ellison Medical Foundation||2012|
|NCI Howard Temin Pathway to Independence Award in Cancer Research (K99/R00)||NIH/NCI||2009|
|Susan G. Komen for the Cure fellow at Rockefeller University||Susan G. Komen for the Cure||2006|